We Grow to Provide the World’s Best Health & Wellness Consumer Cannabis Experience Possible
Aleafia Health’s integrated science and data approach drives our transformational purpose of excellence for the consumer cannabis experience.
With Canada’s largest cannabis medical clinical network, we continuously optimize health and wellness so individuals can live their best life. Aleafia Health is committed to being the world leader in providing physician lead innovation of cannabis health and wellness care based on data, research and experience.
This acquisition creates a global market leader in cannabis health & wellness, driving shareholder value through numerous synergies. Combined, this medical cannabis leader will have renowned national brands, a robust footprint in value-added products and international growth opportunities.
We're leveraging our extensive cannabis patient experience and professional expertise to deliver interactive courseware, gamification, and certifications for the global community. We work to ensure the global community engages responsibly on cannabis health and wellness.
Say hi, new logo.
We have launched our new logo, as we lean in to our pursuit with continuous innovation, research and development; we are creating the the industry’s most reliable cannabis health and wellness consumer experience.
Our evolution is not change for change’s sake. That said, change is inevitable, and exciting to us to embraced, lead and share within the global health and wellness cannabis consumer experience to improve lives thru health and wellness. Aleafia Health will live the pursuit of continuous innovation, powered by technology to scale globally.
Aleafia Campuses are our product innovation hubs where we grow our ideas into global leading innovation and are the core of our cannabis life cycle for health and wellness. Our team’s innovation through patient experience, studies, and cultivation fuels our focus on quality and the consumer cannabis experience.
Aleafia Health has been named the TMX Group’s 2019 TSX Venture 50 top performing company of the year amongst all 2,000 TSX Venture Exchange listed companies. The award was based on three equally weighted criteria, market capitalization growth, share price appreciated and trading volume. This is the first time a cannabis company has achieved top performing status. Honours
Aleafia Health’s first international expansion is through a strategic investment in Australia’s CannaPacific. With 10% equity investment in licensed cannabis cultivator with projected 108,000 sq. ft. greenhouse. Aleafia Health will assist CannaPacific in the establishment of dedicated medical cannabis clinics, with shared expertise across patient treatment and education, physician recruitment and training, treatment best practices and clinic operations
Aleafia Health has entered the fast-growing German medical cannabis Market with a Supply & Distribution Joint-Venture with pharmaceutical wholesaler Acnos Pharma GmbH. The JV will see Aleafia Health leverage Acnos’ robust supply chain network with access to 20,000 pharmacies and will see Aleafia Health ship its branded medical cannabis products to Germany for distribution.
Aleafia Campus Labs has partnered with both Guided 420 Genetics and AKESOgen on a first of its kind cannabis related pharmacogenomics study.
First of its Kind Study Published in Peer-Reviewed Journal, “Cannabis and Cannabinoid Research” Authors Leveraged Aleafia’s 10 Million Point Medical Cannabis Dataset
CEO Geoffrey Benic shares details of the company’s 2019 plans and believes investors are beginning to see the potential of Aleafia’s merger with Emblem Corp.